Dr. Reddy's and Pharmazz inks agreement to market Centhaquine for hypovolemic shock in India
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Pharma Solutions operates 10 research and development and/or production sites globally
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The investment will catalyse various components of the IndiaAI Mission
Acquisition of exclusive commercialization rights for European markets
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
The facility will accommodate over 1,500 employees
Subscribe To Our Newsletter & Stay Updated